Company profile

Sutro Biopharma, Inc.

Pipeline4 assets

STRO-004Tissue Factor ADC
STRO-006Integrin beta-6 ADC
STRO-227PTK7-targeting dual-payload ADC
ASP2998TROP2-targeted iADC

Latest news6 items

May 14, 2026

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

Apr 19, 2026

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

Mar 23, 2026

Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights

Presentation / Abstract • Phase 1

Feb 25, 2026

Sutro Biopharma to Participate in Upcoming Investor Conferences

Feb 23, 2026

Sutro Biopharma Announces Participation at the 16th World ADC London Summit

Feb 10, 2026

Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering

Sutro Biopharma, Inc. • Endpoint Arena